Myocardial Glycogen Turnover in Cardiac Hypertrophy

S. Richardson; A-M. L. Seymour

doi:10.1042/bst028a161

Myocardial Glycogen Turnover in Cardiac Hypertrophy

Biochemical Society Transactions ◽

10.1042/bst028a161 ◽

2000 ◽

Vol 28 (5) ◽

pp. A161-A161

Author(s):

S. Richardson ◽

A-M. L. Seymour

Keyword(s):

Cardiac Hypertrophy ◽

Glycogen Turnover

Download Full-text

421 The NFATc2 isoform plays a major role in calcineurin-induced cardiac hypertrophy

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(06)80283-3 ◽

2006 ◽

Vol 5 (1) ◽

pp. 98-98

Author(s):

M BOURAJJAJ ◽

A ARMAND ◽

B WEIJTS ◽

L DEWINDT

Keyword(s):

Cardiac Hypertrophy

Download Full-text

New potential therapy for cardiac hypertrophy

Nature Middle East ◽

10.1038/nmiddleeast.2016.39 ◽

2016 ◽

Author(s):

Biplab Das

Keyword(s):

Cardiac Hypertrophy

Download Full-text

Sex differences in cardiac hypertrophy are linked to adipose tissue lipolysis

Diabetologie und Stoffwechsel ◽

10.1055/s-0031-1277387 ◽

2011 ◽

Vol 6 (S 01) ◽

Author(s):

A Foryst-Ludwig ◽

M Kreissl ◽

C Sprang ◽

B Thalke ◽

C Böhm ◽

...

Keyword(s):

Sex Differences ◽

Adipose Tissue ◽

Cardiac Hypertrophy ◽

Adipose Tissue Lipolysis

Download Full-text

Faculty Opinions recommendation of Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1030172.358427 ◽

2006 ◽

Author(s):

Fabio Recchia

Keyword(s):

Heart Failure ◽

Cardiac Hypertrophy

Download Full-text

Faculty Opinions recommendation of An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1047225.497149 ◽

2006 ◽

Author(s):

Søren Sheikh

Keyword(s):

Epidermal Growth Factor Receptor ◽

Angiotensin Ii ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cardiac Hypertrophy ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Mutant ◽

Receptor Transactivation

Download Full-text

Faculty Opinions recommendation of Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1048404.503467 ◽

2006 ◽

Author(s):

Raymond Harris

Keyword(s):

Angiotensin Ii ◽

Cardiac Hypertrophy

Download Full-text

Faculty Opinions recommendation of Salt-sensitive hypertension and cardiac hypertrophy in mice deficient in the ubiquitin ligase Nedd4-2.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1113023.568990 ◽

2008 ◽

Author(s):

Sharad Kumar

Keyword(s):

Cardiac Hypertrophy ◽

Ubiquitin Ligase ◽

Salt Sensitive Hypertension

Download Full-text

Faculty Opinions recommendation of A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160858.622278 ◽

2009 ◽

Author(s):

Susan Steinberg

Keyword(s):

Cardiac Hypertrophy ◽

Class Ii ◽

Dependent Pathway

Download Full-text

Faculty Opinions recommendation of RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718888532.793501197 ◽

2014 ◽

Author(s):

David Van Wagoner ◽

Fadia Mayyas

Keyword(s):

Cardiac Hypertrophy ◽

Expression Profiling ◽

Rna Expression ◽

Rna Expression Profiling ◽

Human Ipsc

Download Full-text

Faculty Opinions recommendation of SIRT2 acts as a cardioprotective deacetylase in pathological cardiac hypertrophy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.731387023.793548967 ◽

2018 ◽

Author(s):

Jin-Xiong She ◽

Cong-Yi Wang

Keyword(s):

Cardiac Hypertrophy ◽

Pathological Cardiac Hypertrophy

Download Full-text